Literature DB >> 9210479

The N-terminal region of alpha-dystroglycan is an autonomous globular domain.

A Brancaccio1, T Schulthess, M Gesemann, J Engel.   

Abstract

The structure of the N-terminal region of mouse alpha-dystroglycan (DGN) was investigated by expression of two protein fragments (residues 30-180 and 30-438) in Escherichia coli cells. Trypsin susceptibility experiments show the presence of a stable alpha-dystroglycan N-terminal region (approximately from residue 30 to 315). In addition, guanidinium hydrochloride (Gdn/HCl) denaturation of DGN-(30-438)-peptide, monitored by means of tryptophan fluorescence, produces a cooperative transition typical of folded protein structures. These results strongly suggest that the alpha-dystroglycan N-terminal is an autonomous folding unit preluding a flexible mucin-like region and that its folding is not influenced by the absence of glycosylation. In order to obtain more information on the structural features of the N-terminal domain we have also used circular dichroism, analytical sedimentation and electron microscopy analysis. Circular dichroic spectra show the absence of typical secondary structure (e.g. alpha-helix or beta-sheet) and closely resemble those recorded for loop-containing proteins. This is consistent with a sequence similarity of the alpha-dystroglycan domain with the loop-containing protein elastase. Analytical ultracentrifugation and electron microscopy analysis reveal that the N-terminal domain has a globular structure. DGN-(30-438)-peptide does not bind in the nanomolar range to an iodinated agrin fragment which binds with high affinity to tissue purified alpha-dystroglycan. No binding was detected also to laminin. This result suggests that the alpha-dystroglycan N-terminal domain does not contain the binding site to its extracellular matrix binding partners. It is less likely than the lack of glycosylation reduces its binding affinity, because the N-terminal globular domain only contains two glycosylation sites.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9210479     DOI: 10.1111/j.1432-1033.1997.00166.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  17 in total

1.  Defective mucin-type glycosylation on α-dystroglycan in COG-deficient cells increases its susceptibility to bacterial proteases.

Authors:  Seok-Ho Yu; Peng Zhao; Pradeep K Prabhakar; Tiantian Sun; Aaron Beedle; Geert-Jan Boons; Kelley W Moremen; Lance Wells; Richard Steet
Journal:  J Biol Chem       Date:  2018-07-26       Impact factor: 5.157

Review 2.  The Dystrophin Complex: Structure, Function, and Implications for Therapy.

Authors:  Quan Q Gao; Elizabeth M McNally
Journal:  Compr Physiol       Date:  2015-07-01       Impact factor: 9.090

3.  Post-translational Modification in Muscular Dystrophies.

Authors:  Martina Sandonà; Valentina Saccone
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Alterations of dystrophin-associated glycoproteins in the heart lacking dystrophin or dystrophin and utrophin.

Authors:  Katharine M Sharpe; Monica D Premsukh; DeWayne Townsend
Journal:  J Muscle Res Cell Motil       Date:  2013-10-06       Impact factor: 2.698

5.  TIM-1 Mediates Dystroglycan-Independent Entry of Lassa Virus.

Authors:  Rachel B Brouillette; Elisabeth K Phillips; Radhika Patel; Wadie Mahauad-Fernandez; Sven Moller-Tank; Kai J Rogers; Jacob A Dillard; Ashley L Cooney; Luis Martinez-Sobrido; Chioma Okeoma; Wendy Maury
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

6.  Dystroglycan is associated to the disulfide isomerase ERp57.

Authors:  Francesca Sciandra; Emanuela Angelucci; Fabio Altieri; Daniela Ricci; Wolfgang Hübner; Tamara C Petrucci; Bruno Giardina; Andrea Brancaccio; Manuela Bozzi
Journal:  Exp Cell Res       Date:  2012-07-16       Impact factor: 3.905

7.  A stoichiometric complex of neurexins and dystroglycan in brain.

Authors:  S Sugita; F Saito; J Tang; J Satz; K Campbell; T C Südhof
Journal:  J Cell Biol       Date:  2001-07-23       Impact factor: 10.539

8.  The small leucine-rich repeat proteoglycan biglycan binds to alpha-dystroglycan and is upregulated in dystrophic muscle.

Authors:  M A Bowe; D B Mendis; J R Fallon
Journal:  J Cell Biol       Date:  2000-02-21       Impact factor: 10.539

9.  The Structure of the T190M Mutant of Murine α-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy.

Authors:  Manuela Bozzi; Alberto Cassetta; Sonia Covaceuszach; Maria Giulia Bigotti; Saskia Bannister; Wolfgang Hübner; Francesca Sciandra; Doriano Lamba; Andrea Brancaccio
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

10.  Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan.

Authors:  S Kunz; N Sevilla; D B McGavern; K P Campbell; M B Oldstone
Journal:  J Cell Biol       Date:  2001-10-15       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.